Rotavirus vaccines for children in developing countries: Understanding the science, maximizing the impact, and sustaining the effort
Authors:
- Kathleen M. NeuzilKNKathleen M. Neuzil
- Umesh D. ParasharUPUmesh D. Parashar
- A. Duncan SteeleASA. Duncan Steele
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Efficacy of the oral pentavalent rotavirus vaccine in MaliVaccine, 2012
- Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trialVaccine, 2012
- Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infantsVaccine, 2012
- Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in BangladeshVaccine, 2012
- Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccineVaccine, 2012
- Childhood Diarrhea Deaths after Rotavirus Vaccination in MexicoNew England Journal of Medicine, 2011
- Real-world Impact of Rotavirus VaccinationThe Pediatric Infectious Disease Journal, 2011
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Reduction in Acute Gastroenteritis Hospitalizations among US Children After Introduction of Rotavirus Vaccine: Analysis of Hospital Discharge Data from 18 US StatesThe Journal of Infectious Diseases, 2010